In a report released yesterday, Anne Samuel from J.P. Morgan maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...

IQVIA has seen an increase of 58.97% in its revenues since 2017. Click here to read more about IQV stock and why it is rated ...

Empowered Funds LLC grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 40.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional ...

Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

This was the stock's fourth consecutive day of losses.

This was the stock's third consecutive day of losses.

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent ...

Our fair value estimate is 52% higher than IQVIA Holdings' analyst price target of US$248 In this article we are going to estimate the intrinsic value of IQVIA Holdings Inc. (NYSE:IQV) by estimating ...

J.P. Morgan analyst Anne Samuel maintained a Buy rating on IQVIA Holdings (IQV – Research Report) on February 15 and set a price target of ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year ...